USP22 and hepatocellular carcinoma: To investigate whether RNA interference-mediated USP22 gene silencing affects the growth of HCC cells, the MTT method was used to analyze HepG2 cell viability at 12, 24, 48, 72 and 96 h following transfection with USP22 siRNA.